Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk BioForce Nanosciences Holdings, Inc. per 2025 Jun 30 adalah -0.50 MM.
- Nilai net income untuk BioForce Nanosciences Holdings, Inc. per 2025 Jun 30 adalah -1.30 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -0.50 | -1.30 | |
2025-03-31 | -0.49 | -1.29 | |
2024-12-31 | -0.49 | -0.49 | |
2024-09-30 | -0.48 | -0.48 | |
2024-06-30 | -0.47 | -0.47 | |
2024-03-31 | -0.47 | -0.47 | |
2023-12-31 | -0.47 | -0.47 | |
2023-09-30 | -0.47 | -0.47 | |
2023-06-30 | -0.48 | -0.48 | |
2023-03-31 | -0.48 | -0.48 | |
2022-12-31 | -0.49 | -0.49 | |
2022-09-30 | -0.49 | -0.49 | |
2022-06-30 | -0.48 | -0.48 | |
2022-03-31 | -0.49 | -0.49 | |
2021-12-31 | -0.50 | -0.50 | |
2021-09-30 | -0.50 | -0.50 | |
2021-06-30 | -0.51 | -0.51 | |
2021-03-31 | -0.51 | -0.51 | |
2020-12-31 | -158.41 | -158.41 | |
2020-09-30 | 0.00 | -158.31 | -158.31 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.04 | -0.04 |
2024-12-31 | -0.02 | |
2024-09-30 | -0.02 | -0.02 |
2024-06-30 | -0.02 | -0.02 |
2024-03-31 | -0.02 | -0.02 |
2023-12-31 | -0.02 | |
2023-09-30 | -0.02 | -0.02 |
2023-06-30 | -0.02 | -0.02 |
2023-03-31 | -0.02 | -0.02 |
2022-12-31 | -0.02 | -0.02 |
2022-09-30 | -0.02 | -0.02 |
2022-06-30 | -0.02 | -0.02 |
2022-03-31 | -0.02 | -0.02 |
2021-12-31 | -0.02 | -0.02 |
2021-09-30 | -0.02 | -0.02 |
2021-06-30 | -0.02 | -0.02 |
2021-03-31 | -0.03 | -0.03 |
2020-12-31 | -9.72 | |
2020-09-30 | -10.37 | -10.37 |
2020-06-30 | -10.36 | -10.36 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk BioForce Nanosciences Holdings, Inc. per 2025 Jun 30 adalah -0.07 MM.
- Nilai kas dari aktivitas pendanaan untuk BioForce Nanosciences Holdings, Inc. per 2025 Jun 30 adalah 0.07 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -0.07 | 0.07 | |
2025-03-31 | -0.06 | 0.07 | |
2024-12-31 | -0.06 | 0.06 | |
2024-09-30 | -0.05 | 0.05 | |
2024-06-30 | -0.05 | 0.05 | |
2024-03-31 | -0.04 | 0.04 | |
2023-12-31 | -0.05 | 0.05 | |
2023-09-30 | -0.05 | 0.05 | |
2023-06-30 | -0.06 | 0.05 | |
2023-03-31 | -0.06 | 0.05 | |
2022-12-31 | -0.07 | 0.06 | |
2022-09-30 | -0.07 | 0.04 | |
2022-06-30 | -0.06 | 0.04 | |
2022-03-31 | -0.08 | 0.06 | |
2021-12-31 | -0.08 | 0.05 | |
2021-09-30 | -0.08 | 0.07 | |
2021-06-30 | -0.08 | 0.07 | |
2021-03-31 | -0.07 | 0.06 | |
2020-12-31 | -0.08 | 0.07 | |
2020-09-30 | -0.08 | 0.07 | |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk BioForce Nanosciences Holdings, Inc. pada 2025 Jun 30 adalah -127.03.
- p/tbv untuk BioForce Nanosciences Holdings, Inc. pada 2025 Jun 30 adalah -127.03.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -127.03 | -127.03 | |
2025-03-31 | -15.23 | -15.23 | |
2024-12-31 | -13.30 | -13.30 | |
2024-09-30 | -61.23 | -14.04 | -14.04 |
2024-06-30 | -61.30 | -14.86 | -14.86 |
2024-03-31 | -29.19 | -29.19 | |
2023-12-31 | -128.30 | -35.54 | -35.54 |
2023-09-30 | -145.98 | -44.15 | -44.15 |
2023-06-30 | -77.71 | -25.41 | -25.41 |
2023-03-31 | -209.21 | -75.39 | |
2022-12-31 | -82.41 | -82.41 | |
2022-09-30 | -88.60 | -88.60 | |
2022-06-30 | -164.52 | -80.96 | -80.96 |
2022-03-31 | -67.06 | -39.06 | -39.06 |
2021-12-31 | -69.72 | -47.39 | -47.39 |
2021-09-30 | -83.57 | -67.66 | -67.66 |
2021-06-30 | |||
2021-03-31 | -74.28 | -75.35 | -75.35 |
2020-12-31 | -0.24 | -105.73 | -105.73 |
2020-09-30 | -0.13 | -83.65 | -83.65 |
2020-06-30 | -0.13 | -166.25 | -166.25 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk BioForce Nanosciences Holdings, Inc. pada 2025 Jun 30 adalah -0.04.
- EBIT (3 tahun) / EV untuk BioForce Nanosciences Holdings, Inc. pada 2025 Jun 30 adalah -0.02.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.04 | -0.02 |
2025-03-31 | -0.01 | -0.01 |
2024-12-31 | -0.02 | -0.02 |
2024-09-30 | -0.02 | -0.02 |
2024-06-30 | -0.02 | -0.02 |
2024-03-31 | -0.01 | -0.01 |
2023-12-31 | -0.01 | -0.01 |
2023-09-30 | -0.01 | -0.01 |
2023-06-30 | -0.01 | -0.01 |
2023-03-31 | -0.00 | -0.00 |
2022-12-31 | -0.00 | -0.52 |
2022-09-30 | -0.00 | -0.54 |
2022-06-30 | -0.01 | -0.66 |
2022-03-31 | -0.01 | -1.57 |
2021-12-31 | -0.01 | -1.50 |
2021-09-30 | -0.01 | -1.24 |
2021-06-30 | ||
2021-03-31 | -0.01 | -1.39 |
2020-12-31 | -4.16 | -1.39 |
2020-09-30 | -7.97 | -2.66 |
2020-06-30 | -7.96 | -2.66 |
Efektivitas Manajemen
- roa untuk BioForce Nanosciences Holdings, Inc. pada 2025 Jun 30 adalah -1,940.44.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -1,940.44 | ||||
2025-03-31 | -752.64 | ||||
2024-12-31 | -755.00 | ||||
2024-09-30 | -689.90 | ||||
2024-06-30 | -689.16 | ||||
2024-03-31 | -643.43 | ||||
2023-12-31 | -629.70 | ||||
2023-09-30 | -52.14 | ||||
2023-06-30 | -52.34 | ||||
2023-03-31 | -43.68 | ||||
2022-12-31 | -17.95 | ||||
2022-09-30 | -17.63 | ||||
2022-06-30 | -17.85 | ||||
2022-03-31 | -15.71 | ||||
2021-12-31 | -12.64 | ||||
2021-09-30 | -12.64 | ||||
2021-06-30 | -11.86 | ||||
2021-03-31 | -9.97 | -70.28 | |||
2020-12-31 | -2,689.68 | -3,348.45 | |||
2020-09-30 | -2,992.89 | -3,273.90 | |||
2020-06-30 | -3,370.72 | -3,774.00 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | 0.29 | -26,529.36 | -26,529.36 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1310488 |
Grupong Pang-industriya
SIC 3826 - Laboratory Analytical Instruments |